Table 4.

Cox proportional hazards model for mortality for patients with HCC

Characteristics	Univariable analysis		Multivariable analysis
	HR (95% CI)	P value	HR (95% CI)	P value
Age, years	1.03 (1.01 to 1.05)	0.04	1.05 (1.01 to 1.09)	0.04
Male	1.05 (0.65 to 1.71)	0.84	0.82 (0.43 to 1.55)	0.54
Ethnicity
Caucasian	1 (Referent)		1 (Referent)
Latino/Hispanic	0.51 (0.30 to 0.86)	0.01	0.83 (0.42 to 1.60)	0.57
Asian	0.52 (0.28 to 0.96)	0.04	0.48 (0.21 to 1.10)	0.08
African-American	1.62 (0.65 to 4.05)	0.31	1.11 (0.37 to 3.35)	0.86
Other/Unknown	0.91 (0.33 to 2.54)	0.86	1.15 (0.26 to 5.05)	0.86
Decompensation	1.03 (0.68 to 1.55)	0.90	0.99 (0.54 to 1.84)	0.98
CPT score	1.02 (0.91 to 1.15)	0.73	1.08 (0.93 to 1.25)	0.33
Surveillance
>q12 months or none*	1 (Referent)		1 (Referent)
q6–12 months†	1.20 (0.70 to 2.06)	0.50	1.11 (0.49 to 2.49)	0.81
q6 months‡	0.32 (0.19 to 0.52)	< 0.0001	0.34 (0.16 to 0.72)	0.005
Curative HCC treatment	0.23 (0.14 to 0.40)	<0.0001	0.32 (0.17 to 0.61)	0.001
Within Milan criteria	0.52 (0.34 to 0.79)	0.002	0.69 (0.40 to 1.18)	0.17

*Less often than every 12 months or none.

†Less often than every 6 months but more often than every 12 months.

‡At least every 6 months.

CPT, Child-Pugh-Turcotte; HCC, hepatocellular carcinoma.